BrightSpring Health Services Enters Tangible Equity Unit Agreement
Ticker: BTSGU · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1865782
| Field | Detail |
|---|---|
| Company | Brightspring Health Services, Inc. (BTSGU) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: debt-financing, equity-units, material-agreement
TL;DR
BrightSpring Health Services just signed a deal for some new equity units.
AI Summary
On October 20, 2025, BrightSpring Health Services, Inc. entered into a material definitive agreement related to its Six Point Seven Five Percentage Tangible Equity Units. The company, incorporated in Delaware with its principal executive offices in Louisville, Kentucky, filed this 8-K report on October 22, 2025.
Why It Matters
This filing indicates a significant financial transaction or agreement for BrightSpring Health Services, potentially impacting its capital structure and future financing.
Risk Assessment
Risk Level: medium — The nature of the 'tangible equity units' and their specific terms are not detailed, which could represent a moderate financial risk or opportunity.
Key Numbers
- 6.75% — Interest Rate/Yield (Associated with the Tangible Equity Units)
Key Players & Entities
- BrightSpring Health Services, Inc. (company) — Registrant
- October 20, 2025 (date) — Date of earliest event reported
- Six Point Seven Five Percentage Tangible Equity Units (financial_instrument) — Subject of the material definitive agreement
- Delaware (jurisdiction) — State of Incorporation
- Louisville, Kentucky (location) — Principal Executive Offices
- October 22, 2025 (date) — Filing Date
FAQ
What is the specific nature and purpose of the Six Point Seven Five Percentage Tangible Equity Units?
The filing does not provide specific details on the nature or purpose of these units, only that a material definitive agreement was entered into concerning them.
What are the key terms and conditions of the material definitive agreement?
The filing states that a material definitive agreement was entered into, but the specific terms and conditions are not disclosed in this 8-K summary.
What is the total dollar amount or valuation associated with this tangible equity unit agreement?
The filing does not specify any dollar amounts or valuations related to the tangible equity units.
When is the effective date or closing date of this agreement?
The earliest event reported is October 20, 2025, which is the date the agreement was entered into.
Are there any immediate financial implications for BrightSpring Health Services as a result of this agreement?
The filing indicates a 'material definitive agreement' but does not detail immediate financial implications.
Filing Stats: 815 words · 3 min read · ~3 pages · Grade level 11.8 · Accepted 2025-10-22 16:05:25
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share BTSG The Nasdaq Stock Mar
Filing Documents
- btsg-20251020.htm (8-K) — 56KB
- btsg-ex1_1.htm (EX-1.1) — 352KB
- btsg-ex5_1.htm (EX-5.1) — 23KB
- img18657824_0.jpg (GRAPHIC) — 5KB
- img18657824_1.jpg (GRAPHIC) — 21KB
- 0001193125-25-246752.txt ( ) — 664KB
- btsg-20251020.xsd (EX-101.SCH) — 44KB
- btsg-20251020_htm.xml (XML) — 6KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On October 20, 2025, BrightSpring Health Services, Inc. (the "Company") entered into an underwriting agreement with KKR Phoenix Aggregator L.P. (the "KKR Selling Stockholder"), the Management Selling Stockholders (as defined therein) (together with the KKR Selling Stockholder, the "Selling Stockholders"), and BofA Securities, Inc. (the "Underwriter"), relating to an underwritten offering (the "Offering") of 15,000,000 shares of the Company's common stock, par value $0.01 per share (the "Common Stock"). The closing of the Offering and the Share Repurchase (as defined below) occurred on October 22, 2025. Pursuant to the Underwriting Agreement, all 15,000,000 shares of Common Stock were sold by the Selling Stockholders. The Company did not receive any proceeds from the Offering, other than proceeds received in connection with the cash exercise of stock options by the Management Selling Stockholders in connection with the Offering. The Company purchased 1,500,000 shares of Common Stock from the Underwriter as part of the Offering (the "Share Repurchase"). The Underwriter did not receive any underwriting fees for the shares of Common Stock repurchased by the Company in the Share Repurchase. The Offering by the Selling Stockholders was made pursuant an automatic shelf registration statement on Form S-3ASR (File No. 333-287916) (the "Registration Statement"), filed on June 10, 2025 with the Securities and Exchange Commission (the "SEC"), a prospectus included in the Registration Statement, and a preliminary prospectus supplement and final prospectus supplement, filed with the SEC on October 20, 2025 and October 21, 2025, respectively. The Underwriting Agreement contains customary representations, warranties and covenants, customary conditions to closing, indemnification obligations of the Company, the Selling Stockholders and the Underwriter, including for liabilities under the Securities Act of 1933, as amend
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 1.1 Underwriting Agreement, dated as of October 20, 2025, by and among BrightSpring Health Services, Inc., the Selling Stockholders, and BofA Securities, Inc. 5.1 Opinion of Barnes & Thornburg LLP. 23.1 Consent of Barnes & Thornburg LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRIGHTSPRING HEALTH SERVICES, INC. Date: October 22, 2025 By: /s/ Jennifer Phipps Name: Title: Jennifer Phipps Executive Vice President and Chief Financial Officer